“Knocking at the Door”: Multiomics Getting Closer
Multiomics, rooted in research, is increasingly closing in on clinical practice, to the point that institutions should be at least be ready. This was the
Tariffs – Is IVD OK?
Company Q1 Investor Calls: Most IVD companies have downplayed tariff impact. Small % of revenues affected. Most emphasizing the industry’s having the most advanced supply
In Vitro Diagnostics Stocks, 2025 Flu Season, Diasorin Reports
How are IVD stocks doing in the general market fall? About that huge flu season. A mid-size player reports, which (can be) a measure of
Clinical Laboratory Market Nears $400 Billion: Report
The market for clinical lab services is $396 billion, per a report from our partner Howe Sound Global Clinical Medical Laboratory Services Market – Eye
“It Just Wreaks Havoc” – Webinar Debates Tariff Impact on IVD, LDT Rule Vacation, Other Topics
Multiple topics were discussed at Wednesday’s State of The IVD Industry Webinar. Tariffs. NIH cuts. Proposed Medicaid changes. Agency shakeups. The FDA LDT ruled unlawful
Sepsis Report Details Unique IVD Market Strategy
IVD markets grow faster where there is a need for cost-reduction and outcome improvement. This is true with sepsis. This does not mean every new